Tuesday 30 July 2019

Reuters Health Report: Expensive Gilead, Novartis cancer therapies losing patients to experimental treatments

Reuters.com Newsletter

Expensive Gilead, Novartis cancer therapies losing patients to experimental treatments

Unusually high numbers of U.S. lymphoma patients are choosing experimental treatments over expensive cell therapies sold by Gilead Sciences Inc and Novartis AG , new data shows, helping explain why sales of the two products have not met rosy expectations.

South Africa resumes beef exports to China after foot and mouth outbreak

South Africa has resumed beef exports to China after an outbreak of the highly contagious foot and mouth disease (FMD) in January halted trade, officials said on Tuesday.

J&J says FTC probing efforts to protect arthritis drug Remicade

The Federal Trade Commission issued civil subpoenas to Johnson and Johnson in June as part of an investigation into whether contracting practices for its blockbuster rheumatoid arthritis drug, Remicade, violated antitrust laws, the company said in a regulatory filing on Monday.

U.S. judge blocks Medicaid work requirements in New Hampshire

A federal judge on Monday overturned the Trump administration's approval of a plan by the state of New Hampshire to impose work requirements on people seeking to obtain benefits from the Medicaid health insurance program.

Stillbirth risk in diabetes higher with obesity and high blood sugar

(Reuters Health) - Pregnant women with diabetes may be more likely to experience a stillbirth when they have obesity or poorly controlled blood sugar, a new study suggests.

Riskiest time for surgery patients is not in the operating room

(Reuters Health) - The deadliest time for many surgery patients isn't when they're on the operating table, it's while they're recovering in the hospital and after they go home, a new study suggests.

U.S. doctors giving fewer kids cough and cold medicines

(Reuters Health) - American doctors are recommending cough and cold medicines less often amid a growing recognition that these treatments may be ineffective and lead to serious and potentially fatal side effects, particularly for young kids, a U.S. study suggests.

Most traumatic brain injuries in U.S. kids linked to consumer products

(Reuters Health) - The majority of the more than four million traumatic brain injuries in kids treated in U.S. emergency rooms involved consumer products, a new study suggests.

New York state decriminalizes pot, stops short of Cuomo's legalization call

New York state on Monday decriminalized recreational marijuana use, meaning possession of small amounts of the drug will be punished with fines rather than jail time, a step short of Governor Andrew Cuomo's goal of legalizing pot.

U.S. records 16 new measles cases as outbreak shows signs of slowing

The United States recorded 16 new measles cases between July 18 and July 25, federal health officials said on Monday, as the spread of the disease, which has infected 1,164 people this year in the worst U.S. outbreak since 1992, shows signs of slowing.

Novartis heart drug fails trial, curbing growth prospects

Novartis's heart failure drug Entresto failed a trial in a new use, the Swiss drugmaker said on Monday, calling into question billions of dollars in potential revenue and taking the shine off one of the company's biggest growth prospects.

Related Videos

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS